Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A call to action

BACKGROUND: Critically ill COVID-19 patients have a clear pattern of inflammation and hypercoagulable state. The main aim of the study was to evaluate the outcome of severe COVID-19 patients basing on prothrombotic risk factors (i.e. D-dimer). We also evaluated the impact of different doses of low m...

Descripción completa

Detalles Bibliográficos
Autores principales: Pavoni, Vittorio, Gianesello, Lara, Pazzi, Maddalena, Stera, Caterina, Meconi, Tommaso, Frigieri, Francesca Covani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487146/
https://www.ncbi.nlm.nih.gov/pubmed/32977129
http://dx.doi.org/10.1016/j.thromres.2020.09.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487146/
https://www.ncbi.nlm.nih.gov/pubmed/32977129
http://dx.doi.org/10.1016/j.thromres.2020.09.013

Ejemplares similares